BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16026128)

  • 1. [When and how should hyperprolactinemia be treated?].
    Bachelot A; Courtillot C; Touraine P
    Presse Med; 2005 Jun; 34(10):731-7. PubMed ID: 16026128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases.
    Eren E; Yapıcı Ş; Çakır ED; Ceylan LA; Sağlam H; Tarım Ö
    J Clin Res Pediatr Endocrinol; 2011; 3(2):65-9. PubMed ID: 21750634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation of hyperprolactinemia.
    Luciano AA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current diagnosis and treatment of hyperprolactinemia].
    Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Following patients under treatment for hyperprolactinemia.
    Rebar RW
    J Reprod Med; 1999 Dec; 44(12 Suppl):1100-4. PubMed ID: 10649818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia: etiology, diagnosis, and management.
    Mah PM; Webster J
    Semin Reprod Med; 2002 Nov; 20(4):365-74. PubMed ID: 12536359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the diagnosis and treatment of hyperprolactinemia.
    Biller BM; Luciano A; Crosignani PG; Molitch M; Olive D; Rebar R; Sanfilippo J; Webster J; Zacur H
    J Reprod Med; 1999 Dec; 44(12 Suppl):1075-84. PubMed ID: 10649814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bibliography. Current world literature. Reproductive endocrinology.
    Curr Opin Obstet Gynecol; 2004 Aug; 16(4):356-62. PubMed ID: 15332303
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital.
    Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P
    J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactorrhea: Rapid Evidence Review.
    Bruehlman RD; Winters S; McKittrick C
    Am Fam Physician; 2022 Dec; 106(6):695-700. PubMed ID: 36521467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and reproductive medicine.
    Davis JR
    Curr Opin Obstet Gynecol; 2004 Aug; 16(4):331-7. PubMed ID: 15232488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic evaluation of hyperprolactinemia.
    Biller BM
    J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinemia in children: clinical features and long-term results.
    Catli G; Abaci A; Altincik A; Demir K; Can S; Buyukgebiz A; Bober E
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1123-8. PubMed ID: 23329759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
    Verhelst J; Abs R; Maiter D; van den Bruel A; Vandeweghe M; Velkeniers B; Mockel J; Lamberigts G; Petrossians P; Coremans P; Mahler C; Stevenaert A; Verlooy J; Raftopoulos C; Beckers A
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment options for hyperprolactinemia.
    Faje A; Nachtigall L
    Expert Opin Pharmacother; 2013 Aug; 14(12):1611-25. PubMed ID: 23738973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment of hyperprolactinemia.
    Chanson P; Borson-Chazot F; Chabre O; Estour B
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):113-7. PubMed ID: 17532288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperprolactinemia: causes, diagnosis, and treatment].
    Karasek M; Pawlikowski M; Lewiński A
    Endokrynol Pol; 2006; 57(6):656-62. PubMed ID: 17253440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.